New heart device aims to ease pressure in failing hearts
NCT ID NCT03523416
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early study tests a device that creates a small opening between the upper chambers of the heart to relieve pressure in people with symptomatic heart failure. The study includes 71 participants and focuses on safety and whether the device works as intended. It is not a cure but aims to control the disease and improve symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Transcatheter Atrial Shunt System (a device that creates a small passage between the upper chambers of the heart)
What this could lead to
If it works, this device could offer a new way to manage heart failure symptoms and reduce hospital stays.
What could go wrong
This is an early feasibility study with only 71 people, so it's too soon to know if it's safe or effective. There are risks of heart, brain, or kidney complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abbott Northwestern
Minneapolis, Minnesota, 55407, United States
-
Atrium Health
Charlotte, North Carolina, 28203, United States
-
Kansas University Medical Center
Kansas City, Kansas, 66160, United States
-
Lankenau Institute for Medical Research
Wynnewood, Pennsylvania, 19096, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
St. Vincent Medical Group
Indianapolis, Indiana, 46260, United States
-
Swedish Medical Center
Seattle, Washington, 98122, United States
-
The Christ Hospital
Cincinnati, Ohio, 45219, United States
-
The Ohio State University Medical Center
Columbus, Ohio, 43210, United States
-
UC San Diego Health
La Jolla, California, 92037, United States
-
University California San Francisco
San Francisco, California, 94143, United States
-
University of Florida Health - Jacksonville
Jacksonville, Florida, 32209, United States